Abstract
Despite being the only cardiovascular disease of global impact that has been proven to be completely preventable, rheumatic heart disease remains prevalent in low-income and middle-income countries,1 including those in Africa, where primary prevention programmes are not well established due to lack of available resources.2 An understanding of the epidemiology of rheumatic heart disease has been facilitated through the number of studies published over the past decade, including some on group A streptococcus, the preceding infection thought to initiate the cascade of events leading to permanent valve damage.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
